CEO of drugmaker GSK to step down by year's end

Carbonatix Pre-Player Loader

Audio By Carbonatix

LONDON (AP) — GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.

Walmsley, 56, will be replaced by Luke Miels, currently GSK’s chief commercial officer, the company said in a statement released on Monday.

While GSK achieved a number of strategic successes under Walmsley, including the spinoff of the consumer health care business Haleon, it has disappointed investors. GSK’s shares rose 3.3% to 1534.50 pence in early trading, making it the biggest gainer on the London Stock Exchange.

GSK’s shares fell 11% between April 1, 2017, when Walmsley became CEO, and last Friday.

“Despite the progress, the share price performance has been lackluster,” Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown,” said in a note to investors.

“Although her record of delivering on financial guidance has been strong, the company’s growth rates remain stuck in single-digit territory.”

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • Eric Metaxas Show
    2:00AM - 4:00AM
     
    The Eric Metaxas Show offers compelling perspective on American culture,   >>
     
  • Best of Mike Gallagher
    4:00AM - 6:00AM
     
    Known as "The Happy Conservative Warrior," Mike Gallagher is one of the most consistently popular hosts in America.
     
  • Radio Health Journal
    6:00AM - 6:30AM
     
    Radio Health Journal offers the latest scoop on what’s trending in health,   >>
     
  • Viewpoints Radio
    6:30AM - 7:00AM
     
    Sit down with Viewpoints each week as we report on social issues, the   >>
     
  • Wyatt Matters
    7:00AM - 8:00AM
     
    Wyatt Matters takes a lighthearted approach to things that deeply matter by   >>
     

See the Full Program Guide